| Wnt-Independent SARS-CoV-2 Infection in Pulmonary Epithelial Cells | Microbiology spectrum |  | | 2023 | 194 | 258 |
|
| Clofazimine: a journey of a drug | Biomedicine & pharmacotherapy | | | 2023 | 108 | 485 |
|
| Repositioning the Anti-Leprosy Drug Clofazimine Against Wnt-Dependent Cancers | | | | 2022 | 539 | 939 |
|
| Mining natural compounds to target WNT signaling: land and sea tales | Pharmacology of the WNT signaling system |  | | 2021 | 231 | 1 |
|
| Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo | European Journal of Medicinal Chemistry | | | 2021 | 294 | 229 |
|
| Beyond TNBC: repositioning of clofazimine against a broad range of Wnt-dependent cancers | Frontiers in Oncology | | | 2020 | 347 | 309 |
|
| Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor | Cancer Letters | | | 2019 | 1,156 | 578 |
|
